Bi-monthly hepatic arterial infusion chemotherapy as a novel strategy for advanced hepatocellular carcinoma in decompensated cirrhotic patients

BACKGROUND AND AIMS: We previously reported the comparable efficacy of bi-monthly hepatic arterial infusion chemotherapy (B-HAIC) to that of sorafenib chemotherapy for the treatment of advanced hepatocellular carcinoma (aHCC) in patients with compensated cirrhosis. In this study, we demonstrate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Moriya, Kei, Namisaki, Tadashi, Sato, Shinya, Furukawa, Masanori, Douhara, Akitoshi, Kawaratani, Hideto, Kaji, Kosuke, Shimozato, Naotaka, Sawada, Yasuhiko, Saikawa, Soichiro, Takaya, Hiroaki, Kitagawa, Koh, Akahane, Takemi, Mitoro, Akira, Yamao, Junichi, Yoshiji, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933121/
https://www.ncbi.nlm.nih.gov/pubmed/31405269
http://dx.doi.org/10.3350/cmh.2019.0037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933121/
https://www.ncbi.nlm.nih.gov/pubmed/31405269
http://dx.doi.org/10.3350/cmh.2019.0037

Ejemplares similares